TD Waterhouse Canada Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1999606
TORONTO, A6
Position in VRTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$6,150,641
+$3,552,435 QoQ
Shares Held
13,774
+140.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TD Waterhouse Canada Inc. holds $47,771,505 across 78 Biotechnology names. VRTX ranks #2 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
|
9,564,659 | $33,380,659 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
13,774 | $6,150,641 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,133 | $2,420,681 | |
| 4 | RPRX |
Royalty Pharma plc
|
36,933 | $1,771,676 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,971 | $652,144 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
15,595 | $619,433 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
2,032 | $603,443 | |
| 8 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
81,725 | $591,689 |
All Filings in VRTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,150,641 | 13,774 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,598,206 | 5,731 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $2,192,009 | 5,597 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $6,278,210 | 14,102 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $4,665,422 | 9,623 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $3,559,868 | 8,840 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,141,306 | 2,454 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $452,314 | 965 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $2,213,362 | 5,295 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,730,096 | 4,252 | Shares | Defined | 2024-05-10 | |
| 2023-09-30 | $1,916,047 | 5,510 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,516,028 | 4,308 | Shares | Defined | 2023-11-13 | |
| 2023-03-31 | $364,220 | 1,156 | Shares | Defined | 2023-11-13 | |
| 2022-12-31 | $833,130 | 2,885 | Shares | Defined | 2023-11-13 | |
| 2022-09-30 | $3,226,344 | 11,143 | Shares | Defined | 2023-11-13 | |
| 2022-06-30 | $3,531,674 | 12,533 | Shares | Defined | 2023-11-13 | |
| 2022-03-31 | $3,276,478 | 12,555 | Shares | Defined | 2023-11-13 | |
| 2021-12-31 | $6,432,523 | 29,292 | Shares | Defined | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||